Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19
Titel:
Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19
Auteur:
Lasky, Joseph A. Fuloria, Jyotsna Morrison, Marion E. Lanier, Randall Naderer, Odin Brundage, Tom Melemed, Allen